Spiro-pentacyclic compounds
US7144890B2 · kind B2 · utility
0Cited by
9References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 25, 2005 |
| Grant date | Dec 5, 2006 |
| Priority date | — |
| Expiry date | Jan 25, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of the formula (I)and pharmaceutically acceptable salts thereof, for use as therapeutically active substances. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors including obesity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.